High prevalence and antimicrobial resistance of urinary tract infection isolates in febrile young children without localizing signs in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 2, 2016, Pages 243-248

  Wu, Chang Teng ^a,b   Lee, Hao Yuan ^a,b   Chen, Chyi Liang ^b   Tuan, Pao Lan ^a   Chiu, Cheng Hsun ^a,b  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Febrile young children; Pediatric emergency department; Urinary tract infection

Indexed keywords

AMIKACIN; AMPICILLIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; EMERGENCY WARD; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PROTEUS MIRABILIS; RETROSPECTIVE STUDY; TAIWAN; TEACHING HOSPITAL; URINARY TRACT INFECTION; BACTERIAL INFECTIONS; BACTERIUM; CLASSIFICATION; DRUG EFFECTS; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MYCOSES; NEWBORN; URINARY TRACT INFECTIONS;

BACTERIA; BACTERIAL INFECTIONS; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MYCOSES; PREVALENCE; RETROSPECTIVE STUDIES; TAIWAN; URINARY TRACT INFECTIONS;

EID: 84940688947     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2015.05.016     Document Type: Article

References (36)

1. Al-Saif M.A., Al-Abdi S.Y., Samara J.T., Al-Rahman N.G., Mousa T.A., Alabdulbaqi M.A., et al. Antibiotic sensitivity pattern of common community-acquired uropathogens in children in a Saudi tertiary care hospital. Saudi Med J 2012, 33:565-567.
2. Shaikh N., Morone N.E., Bost J.E., Farrell M.H. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008, 27:302-308.
3. Hoberman A., Wald E.R. Treatment of urinary tract infections. Pediatr Infect Dis J 1999, 18:1020-1021.
4. Zorc J.J., Levine D.A., Platt S.L., Dayan P.S., Macias C.G., Krief W., et al. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics 2005, 116:644-648. Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics.
5. Baker M.D., Bell L.M., Avner J.R. Outpatient management without antibiotics of fever in selected infants. N Engl J Med 1993, 329:1437-1441.
6. Baskin M.N., O'Rourke E.J., Fleisher G.R. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 1992, 120:22-27.
7. Herr S.M., Wald E.R., Pitetti R.D., Choi S.S. Enhanced urinalysis improves identification of febrile infants ages 60 days and younger at low risk for serious bacterial illness. Pediatrics 2001, 108:866-871.
8. Schlager T.A. Urinary tract infections in infants and children. Infect Dis Clin North Am 2003, 17:353-365.
9. Elder J.S. Urologic disorders in infants and children. Nelson textbook of pediatrics 2004, 1785-1790. W. B. Saunders, Philadelphia, PA. 17th ed. R.E. Behrman, R.M. Kliegman, H.B. Jenson (Eds.).
10. Lee H.Y., Chen C.L., Wu S.R., Huang C.W., Chiu C.H. Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients. Crit Care Med 2014, 42:1081-1088.
11. Chen P.C., Chang L.Y., Lu C.Y., Shao P.L., Tsai I.J., Tsau Y.K., et al. Drug susceptibility and treatment response of common urinary tract infection pathogens in children. J Microbiol Immunol Infect 2014, 47:478-483.
12. Ban K.M., Easter J.S. Selected urologic problems. Rosen's Emergency Medicine: Concepts and Clinical Practice 2014, 1326-1354. Mosby Elsevier, Philadelphia, PA. 8th ed. J.A. Marx, R.S. Hockberger, R.M. Walls (Eds.).
13. Norrby S.R. Approach to the patient with urinary tract infection. Goldman's Cecil Medicine 2015, 1872-1876. Saunders Elsevier, Philadelphia, PA. 25th ed. L. Goldman, A.I. Schafer (Eds.).
14. Stein R., Dogan H.S., Hoebeke P., Kočvara R., Nijman R.J., Radmayr C., et al. Urinary tract infections in children: EAU/ESPU Guidelines. Eur Urol 2015, 67:546-558.
15. Ramage I.J., Chapman J.P., Hollman A.S., Elabassi M., McColl J.H., Beattie T.J. Accuracy of clean-catch urine collection in infancy. J Pediatr 1999, 135:765-767.
16. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts K.B. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011, 128:595-610.
17. Bauer A.W., Kirby W.M., Sherris J.C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966, 45:493-496.
18. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: 24th informational supplement 2014, Document M100-S24, CLSI, Wayne, PA.
19. Lin D.S., Huang S.H., Lin C.C., Tung Y.C., Huang T.T., Chiu N.C., et al. Urinary tract infection in febrile infants younger than eight weeks of age. Pediatrics 2000, 105:E20.
20. Ginsburg C.M., McCracken G.H. Urinary tract infections in young infants. Pediatrics 1982, 69:409-412.
21. American Academy of Pediatrics Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 1999, 103:843-852. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection.
22. Wiswell T.E., Roscelli J.D. Corroborative evidence for the decreased incidence of urinary tract infections in circumcised male infants. Pediatrics 1986, 78:96-99.
23. Kizilca O., Siraneci R., Yilmaz A., Hatipoglu N., Ozturk E., Kiyak A., et al. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int 2012, 54:858-862.
24. Ashkenazi S., Even-Tov S., Samra Z., Dinari G. Uropathogens of various childhood populations and their antibiotic susceptibility. Pediatr Infect Dis J 1991, 10:742-746.
25. Hellerstein S. Urinary tract infections: old and new concepts. Pediatr Clin North Am 1996, 42:1433-1457.
26. Hoberman A., Wald E.R., Kickey R.W., Baskin M., Charron M., Majd M., et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999, 104:79-86.
27. McLoughlin T.G., Joseph M.M. Antibiotic resistance patterns of uropathogens in pediatric emergency department patients. Acad Emerg Med 2003, 10:347-351.
28. Marcus N., Ashkenazi S., Samra Z., Cohen A., Livni G. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment. Infection 2008, 36:421-426.
29. Ladhani S., Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003, 88:444-445.
30. Yüksel S., Oztürk B., Kavaz A., Ozçakar Z.B., Acar B., Güriz H., et al. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agent 2006, 28:413-416.
31. Pape L., Gunzer F., Ziesing S., Pape A., Offner G., Ehrich J.H. Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection. Klin Padiatr 2004, 216:83-86. [In German].
32. Allen U.D., MacDonald N., Fuite L., Chan F., Stephens D. Risk factors for resistance to ''first-line'' antimicrobials among urinary tract isolates of Escherichia coli in children. Can Med Assoc J 1999, 160:1436-1440.
33. Wu C.Y., Chiu P.C., Hsieh K.S., Chiu C.L., Shih C.H., Chiou Y.H. Childhood urinary tract infection: a clinical analysis of 597 cases. Acta Paediatr Taiwan 2004, 45:328-333.
34. Grover S.S., Sharma N., Chattopadhya D., Kapoor H., Pasha S.T., Singh G. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin. J Infect 2006, 53:279-288.
35. Mathai D., Rhomberg P.R., Biedenbach D.J., Jones R.N. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagn Microbiol Infect Dis 2002, 44:367-377. India Antimicrobial Resistance Study Group.
36. Mohanty S., Singhal R., Sood S., Dhawan B., Das B.K., Kapil A. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against Gram negative bacteria. Indian J Med Res 2005, 122:425-428.